Description
Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)
Article: Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)
€3.03
€3.03
Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)
Top